X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (270179) 270179
Book Review (31212) 31212
Publication (11713) 11713
Newsletter (9728) 9728
Newspaper Article (7346) 7346
Book Chapter (1907) 1907
Conference Proceeding (1613) 1613
Dissertation (808) 808
Magazine Article (631) 631
Trade Publication Article (258) 258
Book / eBook (235) 235
Web Resource (179) 179
Government Document (104) 104
Reference (52) 52
Paper (31) 31
Transcript (27) 27
Data Set (10) 10
Journal / eJournal (8) 8
Report (4) 4
Streaming Video (3) 3
Presentation (2) 2
Library Holding (1) 1
Spoken Word Recording (1) 1
Technical Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (206484) 206484
humans (171694) 171694
male (79915) 79915
animals (71450) 71450
female (71160) 71160
middle aged (44296) 44296
adult (41316) 41316
blood platelets (36150) 36150
hematology (35337) 35337
platelets (34103) 34103
aged (31805) 31805
abridged index medicus (28084) 28084
blood platelets - metabolism (23791) 23791
platelet aggregation - drug effects (20461) 20461
mice (19991) 19991
blood platelets - drug effects (19344) 19344
rats (19284) 19284
platelet count (19141) 19141
peripheral vascular disease (18010) 18010
platelet aggregation inhibitors - therapeutic use (17895) 17895
biochemistry & molecular biology (17628) 17628
platelet aggregation (16651) 16651
research (15522) 15522
platelet-derived growth factor (15416) 15416
time factors (15210) 15210
cardiac & cardiovascular systems (15104) 15104
blood platelets - physiology (13939) 13939
risk factors (13760) 13760
cell biology (13695) 13695
pharmacology & pharmacy (13663) 13663
cells, cultured (12711) 12711
treatment outcome (12693) 12693
thrombosis (12626) 12626
analysis (12331) 12331
activation (12051) 12051
surgery (11946) 11946
in vitro techniques (11703) 11703
blood (11164) 11164
adolescent (11072) 11072
expression (10944) 10944
aspirin (10373) 10373
platelet (10034) 10034
aggregation (9681) 9681
platelet activation (9329) 9329
rabbits (9296) 9296
inflammation (9252) 9252
oncology (9152) 9152
platelet aggregation inhibitors - pharmacology (9105) 9105
cells (8637) 8637
care and treatment (8615) 8615
dose-response relationship, drug (8590) 8590
aged, 80 and over (8338) 8338
medicine, general & internal (8108) 8108
immunology (8105) 8105
proteins (8031) 8031
plasma (7820) 7820
kinetics (7737) 7737
aspirin - therapeutic use (7615) 7615
ticlopidine - analogs & derivatives (7537) 7537
disease (7498) 7498
medicine, research & experimental (7475) 7475
cancer (7454) 7454
retrospective studies (7382) 7382
child (7249) 7249
platelet aggregation inhibitors - administration & dosage (7230) 7230
health aspects (7163) 7163
clopidogrel (7077) 7077
signal transduction (6974) 6974
prospective studies (6857) 6857
thrombocytopenia (6841) 6841
pregnancy (6633) 6633
phosphorylation (6631) 6631
risk (6602) 6602
inhibition (6557) 6557
in-vitro (6450) 6450
platelet-rich plasma (6402) 6402
prognosis (6401) 6401
mortality (6335) 6335
therapy (6280) 6280
physiological aspects (6168) 6168
atherosclerosis (6129) 6129
flow cytometry (6084) 6084
platelet aggregation inhibitors - adverse effects (6070) 6070
thrombin (5975) 5975
blood platelets - immunology (5957) 5957
medicine (5896) 5896
blood platelets - cytology (5761) 5761
molecular sequence data (5740) 5740
platelet transfusion (5727) 5727
blood platelets - enzymology (5646) 5646
patients (5609) 5609
article (5562) 5562
adenosine diphosphate - pharmacology (5523) 5523
medical research (5503) 5503
blood coagulation (5418) 5418
collagen (5406) 5406
disease models, animal (5386) 5386
dogs (5358) 5358
drug therapy, combination (5277) 5277
anticoagulants - therapeutic use (5254) 5254
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (182) 182
Online Resources - Online (68) 68
Collection Dvlpm't (Acquisitions) - Vendor file (10) 10
Collection Dvlpm't (Acquisitions) - Closed Orders (7) 7
UofT at Scarborough - Stacks (4) 4
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (3) 3
UofT at Mississauga - Stacks (3) 3
Chemistry (A D Allen) - Stacks (2) 2
Dentistry (Harry R Abbott) - Stacks (2) 2
UTL at Downsview - May be requested (2) 2
Gerstein Science - Periodical Stacks (1) 1
Gerstein Science - Theses (1) 1
Media Commons - Audio Visual (1) 1
Mt Sinai Hospital - Online (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Online (1) 1
St. Michael's Hospital - Stacks (1) 1
University Archives - Archives (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (264691) 264691
German (5889) 5889
French (4121) 4121
Russian (3997) 3997
Japanese (3808) 3808
Chinese (2807) 2807
Italian (1268) 1268
Polish (1165) 1165
Spanish (1139) 1139
Portuguese (459) 459
Korean (386) 386
Czech (365) 365
Hungarian (225) 225
Dutch (162) 162
Turkish (148) 148
Danish (144) 144
Swedish (131) 131
Norwegian (96) 96
Croatian (91) 91
Ukrainian (79) 79
Serbian (77) 77
Romanian (76) 76
Slovak (72) 72
Hebrew (67) 67
Bulgarian (62) 62
Finnish (45) 45
Persian (39) 39
Lithuanian (25) 25
Slovenian (8) 8
Bosnian (7) 7
Indonesian (7) 7
Icelandic (6) 6
Afrikaans (3) 3
Greek (3) 3
Arabic (2) 2
Estonian (1) 1
Gaelic (1) 1
Latvian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal
Microscopy and Microanalysis, ISSN 1431-9276, 08/2018, Volume 24, Issue S1, pp. 1250 - 1251
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2015, Volume 135, Issue 6, pp. 1424 - 1432
Anaphylaxis is an acute, severe, life-threatening multisystem allergic reaction resulting from the sudden systemic release of biochemical mediators and... 
Allergy and Immunology | Allergy | signaling | mediators | receptor antagonists | anaphylaxis | platelet-activating factor | mast cells | acetylhydrolase | platelets | sepsis | PHOSPHOLIPASE A INHIBITOR | CLINICAL-TRIAL | IMMUNOLOGY | FACTOR ACETYLHYDROLASE ACTIVITY | PHASE-II TRIAL | FACTOR PAF | FACTOR RECEPTOR ANTAGONIST | DOUBLE-BLIND | HUMAN NASAL AIRWAY | CORONARY-ARTERY-DISEASE | SEVERE SEPSIS | Blood Platelets - pathology | Blood Platelets - immunology | Humans | Platelet Activation - immunology | Platelet Activating Factor - immunology | Eosinophils - immunology | 1-Alkyl-2-acetylglycerophosphocholine Esterase - immunology | Receptors, G-Protein-Coupled - immunology | 1-Alkyl-2-acetylglycerophosphocholine Esterase - genetics | Sepsis - pathology | Asthma - immunology | Anaphylaxis - immunology | Eosinophils - pathology | Platelet Aggregation - genetics | Neutrophils - pathology | Mast Cells - immunology | Platelet Membrane Glycoproteins - immunology | Sepsis - immunology | Platelet Aggregation - immunology | Signal Transduction | Anaphylaxis - pathology | Gene Expression Regulation | Neutrophils - immunology | Platelet Activating Factor - genetics | Platelet Membrane Glycoproteins - genetics | Asthma - genetics | Sepsis - genetics | Anaphylaxis - genetics | Platelet Activation - genetics | Mast Cells - pathology | Receptors, G-Protein-Coupled - genetics | Asthma - pathology | Enzymes | Immune response | Anaphylaxis | Permeability | Metabolites | Analysis | Proteins | Antigens | Blood platelets | E coli | Rodents | Preeclampsia | Lipids | Smooth muscle | Carbon | Biological activity | Index Medicus | Abridged Index Medicus
Journal Article
Transfusion, ISSN 0041-1132, 06/2005, Volume 45, Issue 6, pp. 911 - 919
BACKGROUND: Several strategies are being developed to reduce the risk of pathogen transmission associated with platelet (PLT) transfusion. STUDY DESIGN AND... 
STORAGE | PROMOTE PROCOAGULANT ACTIVITY | MEMBRANE-GLYCOPROTEINS | FLOW CONDITIONS | HEMOSTATIC EFFECTIVENESS | BLEEDING-TIME | ARTERY SUBENDOTHELIUM | ANNEXIN-V | TRANSFUSION MEDICINE | BLOOD-FLOW | HEMATOLOGY | P-Selectin - radiation effects | Platelet Adhesiveness - radiation effects | Blood Platelets - radiation effects | Temperature | Fibronectins - radiation effects | Platelet Glycoprotein GPIIb-IIIa Complex - radiation effects | Blood Preservation | Humans | Annexin A5 - drug effects | Platelet Membrane Glycoprotein IIb - analysis | Riboflavin - pharmacology | Blood Platelets - physiology | Fibrinogen - radiation effects | Antigens, CD - analysis | Flow Cytometry | Ultraviolet Rays | von Willebrand Factor - drug effects | Time Factors | Blood Platelets - cytology | Platelet Glycoprotein GPIIb-IIIa Complex - drug effects | Plateletpheresis | Annexin A5 - analysis | Platelet Glycoprotein GPIb-IX Complex - radiation effects | P-Selectin - analysis | Blood Platelets - drug effects | Lysosome-Associated Membrane Glycoproteins | Antigens, CD - radiation effects | Fibrinogen - drug effects | Platelet Glycoprotein GPIb-IX Complex - drug effects | Platelet Membrane Glycoprotein IIb - drug effects | von Willebrand Factor - analysis | Fibronectins - analysis | Platelet Glycoprotein GPIb-IX Complex - analysis | Blood Platelets - chemistry | Platelet Transfusion | Annexin A5 - radiation effects | Platelet Membrane Glycoprotein IIb - radiation effects | Antigens, CD - drug effects | Platelet Glycoprotein GPIIb-IIIa Complex - analysis | Fibronectins - drug effects | Platelet Adhesiveness - drug effects | P-Selectin - drug effects | Platelet Count | von Willebrand Factor - radiation effects | Fibrinogen - analysis | Platelet Activation - drug effects | Platelet Activation - radiation effects | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2016, Volume 11, Issue 10, pp. e0163006 - e0163006
Thioredoxin (Trx) is an oxidoreductase with important physiological function. Imbalances in the NADPH/thioredoxin reductase/thioredoxin system are associated... 
PROTEIN-DISULFIDE-ISOMERASE | FORMATION IN-VIVO | ENDOTHELIUM | MULTIDISCIPLINARY SCIENCES | BONDS | REDUCTASE | RECEPTOR | CANCER | ASSOCIATION | EXPRESSION | PROGRESSION | Platelet Function Tests - methods | Benzothiazoles - pharmacology | Humans | Imidazoles - pharmacology | Hydroquinones - pharmacology | Platelet Adhesiveness - drug effects | Receptors, Collagen - metabolism | Thrombosis - metabolism | Thioredoxins - pharmacology | Ristocetin - pharmacology | Blood Platelets - metabolism | Platelet Membrane Glycoproteins - metabolism | Platelet Aggregation Inhibitors - pharmacology | Blood Coagulation Tests - methods | Disulfides - pharmacology | Platelet Activation - drug effects | Platelet Aggregation - drug effects | Thrombosis - drug therapy | Blood Platelets - drug effects | von Willebrand Factor - metabolism | Thiols | Collagen | Von Willebrand factor | Physiological aspects | Oxidoreductases | Thioredoxin | Thrombosis | Blood clot | Neurosciences | Peptides | Oxidoreductase | Clinical trials | Activation | Kinases | Cell surface | Proteins | Receptors | Blood platelets | Chemical bonds | Physiology | Oxidation | Inhibition | Agglutination | NADP | Thromboembolism | Enzymes | Medical research | Pharmacology | Rutin | Substrates | Blood clots | Endothelium | Pathology | Valence | Inhibitors | Acids | Proteomics | Ligands | Platelets | Binding sites | Ristocetin | Cancer | Apoptosis | Reductase | Index Medicus
Journal Article
1997, Handbook of experimental pharmacology, ISBN 9783540619970, Volume 126., xxviii, 753
Book
Blood, ISSN 0006-4971, 12/2012, Volume 120, Issue 25, pp. 5041 - 5049
Journal Article
2005, Contemporary cardiology (Totowa, N.J. : Unnumbered), ISBN 1588292444, xi, 397
A cutting-edge review of the latest findings on the complexities of platelet function and the various means of inhibiting platelet clot formation. The authors... 
Blood platelet disorders | Clinical & internal medicine | Diagnosis | Blood platelets | Examination | Medicine & Public Health | Cardiology
Book
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 08/2017, Volume 15, Issue 8, pp. 1646 - 1654
Background: After three miscarriages, a 39-year-old woman gave birth, with a 1-year interval, to two severely thrombocytopenic neonates (4 x10(9) L-1 and 33... 
GPI | neonatal alloimmune | thrombocytopenia | complex | platelet | platelet glycoprotein | human platelet antigens | platelets | platelet glycoprotein IX | platelet GPIb–IX complex | POINT MUTATION | REACTIVE ANTIBODIES | ALPHA INTEGRIN | IMMUNE THROMBOCYTOPENIA | BERNARD-SOULIER-SYNDROME | PERIPHERAL VASCULAR DISEASE | FETOMATERNAL ALLOIMMUNE THROMBOCYTOPENIA | SEQUENCE ALIGNMENTS | HEMATOLOGY | platelet GPIb-IX complex | ALLOANTIGEN | BETA INTEGRIN | ANTIBODY-SPECIFIC IMMOBILIZATION | Humans | Isoantibodies - blood | Platelet Glycoprotein GPIb-IX Complex - metabolism | Thrombocytopenia, Neonatal Alloimmune - diagnosis | Transfection | DNA Mutational Analysis | Thrombocytopenia, Neonatal Alloimmune - blood | Fatal Outcome | HEK293 Cells | Female | Infant, Newborn | Serologic Tests | Genetic Predisposition to Disease | Platelet Transfusion | Antigens, Human Platelet - blood | Treatment Outcome | Heredity | Antigens, Human Platelet - immunology | Pregnancy | Phenotype | Thrombocytopenia, Neonatal Alloimmune - therapy | Antigens, Human Platelet - genetics | Pedigree | Platelet Glycoprotein GPIb-IX Complex - genetics | Thrombocytopenia, Neonatal Alloimmune - genetics | Mutation | Platelet Glycoprotein GPIb-IX Complex - immunology | Infants (Newborn) | Thrombocytopenia | Antigens | Transfusion | Blood platelets | Cesarean section | Neonates | Flow cytometry | Nucleotide sequence | Fetuses | Immobilization | Gestation | Polymerase chain reaction | Isoimmunization | Genotyping | Gene frequency | Alleles | Monoclonal antibodies | Alloantibodies | Children | Platelets | DNA sequencing | Index Medicus
Journal Article
Circulation, ISSN 0009-7322, 05/2011, Volume 123, Issue 17, pp. 1891 - 1899
Background-Blocking of glycoprotein VI-dependent pathways by interfering in vascular collagen sites is commonly seen as an attractive target for an... 
stroke | platelet aggregation inhibitors | platelet adhesion | glycoprotein VI | platelet aggregation | CARDIAC & CARDIOVASCULAR SYSTEMS | FAB FRAGMENT | THROMBUS FORMATION | ACUTE CORONARY SYNDROME | ADHESION | CLOPIDOGREL | IN-VIVO | PERIPHERAL VASCULAR DISEASE | SOLUBLE GPVI | MICE | HEMATOLOGY | ANTITHROMBOTIC PROTECTION | EXPRESSION | Injections, Intravenous | Cricetulus | Recombinant Fusion Proteins - adverse effects | Humans | Male | Immunoglobulin Fc Fragments - administration & dosage | Dose-Response Relationship, Drug | Young Adult | Platelet Aggregation Inhibitors - administration & dosage | Platelet Membrane Glycoproteins - administration & dosage | Adult | Platelet Membrane Glycoproteins - adverse effects | Platelet Aggregation - drug effects | Platelet Aggregation Inhibitors - pharmacokinetics | Immunoglobulin Fc Fragments - adverse effects | Recombinant Fusion Proteins - administration & dosage | CHO Cells | Platelet Aggregation Inhibitors - adverse effects | Hemostasis - drug effects | Platelet Membrane Glycoproteins - pharmacokinetics | Cricetinae | Glycoproteins - administration & dosage | Collagen - administration & dosage | Animals | Platelet Count | Recombinant Fusion Proteins - pharmacokinetics | Aggregation | Safety and security measures | Blood platelets | Hemostasis | Patient outcomes | Atherosclerosis | Dosage and administration | Research | Drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Circulation: Cardiovascular Interventions, ISSN 1941-7640, 12/2012, Volume 5, Issue 6, pp. 797 - 804
Background-Ticagrelor and prasugrel provide stronger platelet inhibition compared with clopidogrel. Direct pharmacodynamic comparison between them has not yet... 
Prasugrel | Pharmacology | Platelets | Ticagrelor | Platelet reactivity | prasugrel | CARDIAC & CARDIOVASCULAR SYSTEMS | PLATO TRIAL | platelet reactivity | ticagrelor | DOSE CLOPIDOGREL | platelets | PERCUTANEOUS CORONARY INTERVENTION | INHIBITION | TASK-FORCE | pharmacology | TREATMENT PLATELET REACTIVITY | OUTCOMES | ASSOCIATION | AGGREGATION | ARTERY-DISEASE | Piperazines - administration & dosage | Single-Blind Method | Myocardial Infarction - blood | Prasugrel Hydrochloride | Thiophenes - therapeutic use | Prospective Studies | Purinergic P2Y Receptor Antagonists - administration & dosage | Thiophenes - adverse effects | Humans | Middle Aged | Receptors, Purinergic P2Y12 - drug effects | Male | Thiophenes - administration & dosage | Greece | Myocardial Infarction - therapy | Purinergic P2Y Receptor Antagonists - adverse effects | Time Factors | Adenosine - adverse effects | Adenosine - therapeutic use | Platelet Aggregation Inhibitors - administration & dosage | Platelet Function Tests | Female | Platelet Aggregation - drug effects | Blood Platelets - drug effects | Platelet Aggregation Inhibitors - therapeutic use | Receptors, Purinergic P2Y12 - metabolism | Purinergic P2Y Receptor Antagonists - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Drug Administration Schedule | Linear Models | Treatment Outcome | Piperazines - therapeutic use | Adenosine - administration & dosage | Piperazines - adverse effects | Blood Platelets - metabolism | Adenosine - analogs & derivatives | Least-Squares Analysis | Aged | Percutaneous Coronary Intervention - adverse effects | Index Medicus
Journal Article